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Edited by Robert BaroukiAbstract We identiﬁed MafG as a protein that interacts with
HIF-1a, a key factor in hypoxic response, using the yeast two-
hybrid system. Interaction between MafG and HIF-1a was con-
ﬁrmed by surface plasmon resonance and by translocation to the
nucleolus with the NoLS signal. A knockdown of MafG reduced
erythropoietin (EPO) mRNA levels as well as luciferase reporter
activity with the hypoxia response element. The knockdown of
MafG did not change total HIF-1a protein, but reduced the
accumulation of HIF-1a in the nuclei. These results suggest that
MafG regulates the hypoxic response of cells by detaining HIF-
1a in the nuclei.
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HIF1A (uniprotkb:Q16665) physically interacts (MI:0218) with
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HIF1A (uniprotkb:Q16665) physically interacts (MI:0218) with
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MINT-6550948:
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The transcriptional response to hypoxia is regulated by the
hypoxia-inducible factors (HIFs), which are heterodimeric
transcription factors consisting of a regulated alpha subunit
(HIF-1a or HIF-2a) and a constitutive subunit (aryl hydrocar-
bon receptor nuclear translocator, ARNT/HIF-1b) [1,2]. HIF
proteins belong to the basic helix-loop-helix-per/ARNT/Sim
(bHLH-PAS) family of transcription factors, which are in-
volved in sensing and responding to changes in environmental
conditions. HIF-1a contains two PAS domains, designated
PAS-A and PAS-B [3]. HIF-1a PAS domains have been func-
tionally implicated in heterodimer formation with ARNT, nu-
clear localization, stabilization via heat-shock protein 90
(HSP90) association, and possibly target gene speciﬁcity via
interactions with currently unidentiﬁed factors [4]. HSP90
plays a pivotal role in mediating the proper folding of a target
protein and cooperates with the proteasomal pathway to elim-
inate misfolded cellular proteins [5,6]. In the cytoplasm, HIF-
1a is stabilized by association with HSP90, while in the nucleus
HIF-1a is released from HSP90 by competing with ARNT [3].
In place of HSP90, ARNT stabilizes HIF-1a, whose complex
binds to the cis-acting sequence, the hypoxia response element
(HRE). The fundamental properties of HIF-1a are inﬂuenced
by its choice of a PAS-associated binding partner.
In this study, we used a yeast two-hybrid system to search
for a new protein that interacts with HIF-1a. As a result, we
identiﬁed a small Maf protein, MafG [7]. The small Maf pro-
teins, including MafF, MafG, and MafK, each possess a basic
leuicine zipper (bZip) domain that is required for homodimer
or heterodimer complex formation with other bZip transcrip-
tion factors such as Nrf2 [8]. Nrf2 is an essential component
for expression of anti-oxidant enzymes. In nrf2-null mutant
mice, the toxicity of electrophiles and reactive oxygen species
(ROS) was increased, indicating that Nrf2 plays an important
role in protection against oxidative stress [9]. Nrf2 transcrip-
tional activity is controlled by an interaction between Nrf2
and its regulatory protein, Keap1 [9]. Nrf2 is released from
Keap1 by electrophiles or ROS, leading to the translocation
of Nrf2 to the nucleus, followed by the interaction with MafG
[10]. MafG-deﬁcient mice exhibited impaired megakaryopoie-
sis and behavioral abnormalities [11]. The former phenotypic
abnormality is similar to that in mice deﬁcient in p45 which
is a partner of MafG in the formation of the complex
NF-E2 [12] However, the latter impairment, that of behav-
ioral abnormalities speciﬁcally responsible for the observed
behavioral phenotypes are yet to be determined [13]. On the
other hand, null mutation of HIF-1a causes dysregulatedblished by Elsevier B.V. All rights reserved.
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a reduction in neural cells and an impairment of spatial mem-
ory [14]. The study of functional loss in both HIF-1a and
MafG shows that these factors contribute to the growth or dif-
ferentiation of neuronal cells, suggesting a possible interaction
between HIF-1a and MafG. In this study, we conﬁrmed the
interaction between HIF-1a and MafG in the nuclei of cells
and investigated the biological roles of MafG in the HIF-
dependent hypoxic response of cells.2. Materials and methods
2.1. Materials
The Matchmaker GAL4 two-hybrid system 3, pCMV-HA and
pCMV-Myc vectors, and a human heart library were obtained from
Clontech Laboratories (Mountain View, CA). pGEM-T easy vector
and the dual-luciferase assay kit were purchased from Promega (Mad-
ison, WI). Dulbeccos modiﬁed Eagles medium, fetal bovine serum,
and antibodies against HIF-1a (cat#, H6536), b-actin (cat#, A5316)
and HSP90 (cat#, H-1775) were purchased from Sigma Chemical
(St. Louis, MO). pBAsi-hU6 Neo vector was purchased from Takara
Bio (Shiga, Japan).
2.2. Construction of HIF-1a-pAS2 plasmid and yeast two-hybrid assay
A 732-bp fragment including the bHLH and PAS-A domains of
HIF-1a was cut out from HIF-1a (full length) in pBluescript II plasmid
by the NdeI and SalI sites [15]. The Matchmaker GAL4 two-hybrid
system was used to perform yeast two-hybrid screening according to
the manufacturers instructions. This 732-bp fragment (including 244
amino acid residues) of HIF-1a in pAS2-1 was used as a bait. The
PAS-B domain was removed because it interacts with HSP90 and
ARNT [3]. Human heart Matchmaker library was used as an AD li-
brary. A total of 2 · 106 transformants were screened in yeast strain
AH109. A 732-bp fragment of HIF-1a was also subcloned into the
pQE vector (Qiagen, Hilden, Germany) and the PAS-A domain was
expressed in Escherichia coli and puriﬁed PAS-A domain was used
for surface Plasmon resonance analysis.
2.3. Preparation of MafG and MafK constructs
Full-length cDNAs of MafG (GenBank accession no. NM002359)
and MafK (GenBank accession no. NM002360) were obtained by
reverse transcription-polymerase chain reaction (RT-PCR) using the
speciﬁc primers. The sequences of the primers used for MafG were
5 0-AACCGCGGCGATGACGACCCCCAATAAAG-3 0 (underline:
start codon) and 5 0-GCAGACGCGCGTCCCTACGA-3 0 (underline:
stop codon). The sequence of primers used for MafK were 5 0-
GGGAATTCGTTATGACGACTAATCCCAA-3 0 (underline: EcoRI
site; double underline: start codon) and 5 0-CCCAAGCTTGAT-
GTCGAGAGTCTGCATCC-3 0 (underline: BamHI site; stop codon
is upstream of this primer). PCR was performed using a reaction mix-
ture containing 10 pmol of each primer, 1.5 units of Gene Amp Hi
Fidelity Taq DNA polymerase (Applied Biosystems, Foster City,
CA), and 100 ng of cDNA according to the following protocol:
2 min at 94 C and 30 cycles of 30 s at 94 C, 30 s at 55 C, and 30 s
at 72 C, plus a ﬁnal extension for 5 min at 72 C. The ampliﬁed
DNA was subcloned into pGEM by the T-A cloning method accord-
ing to the manufacturers instructions (Promega). Full-length cDNA of
MafG was then subcloned into pcDNA3.1 in the sense and anti-sense
directions for over-expression or knockdown of these proteins in mam-
malian cells. Furthermore, MafG cDNA was subcloned into mamma-
lian expression plasmid pEGFP-N1 including GFP at the C-terminus
(designated pEGFP-N1-MafG). DNA fragment of NoLS [16] was syn-
thesized using Hep3B cell cDNA as a template with the following
primers: sense primer 5 0-AAGGATCCCAGCAAGAGGCCCAGGC-
GAC-3 0 and anti-sense primer 5 0-AAGGATCCGATCCGTGG-
CCTTGGAGTC-3 0 (underline: BamHI site). The ampliﬁed
fragment was inserted into pEGFP-N1-MafG between MafG
and GFP with the BamHI site (designated MafG-NoLS-
GFP). For the knockdown of MafG with siRNA, a speciﬁc re-
gion of MafG sequence was designated (656-676 of MafGcDNA sequence of NM002359). The sense, anti-sense, and
hairpin sequences were inserted into the pBAsi-hU6 Neo vec-
tor stepwise according to the manufacturers instructions.
The sequence of inserted nucleotide for MafG-knockdown is
as follow: 5 0-GTTTACTATTGTGATGACGCTGCCCCT-
GTGAAGCCACAGATGGGGGGGCGTCATACAATAG-
TAAATTTTTT-3 0 (underline: 656–676th nucleotide in MafG
and complementary sequence each other; double underline:
hairpin region). The full-length cDNAs of MafG and MafK
were also subcloned into the pQE vector (Qiagen, Hilden,
Germany), which has a His tag in the N-terminal, and was ex-
pressed in E. coli BL21 Codon Plus cells according to the man-
ufacturers instructions (Stratagene, La Jolla, CA) for surface
plasmon resonance analysis and for antibody preparation [15].
2.4. Preparation of MafGDZip and Zip domain of MafG constructs
MafG lacking the leucine zipper (Zip) domain (MafGDZip) includ-
ing 83 amino acids (1–83th amino acid of MafG) and Zip domain of
MafG including 79 amino acids (84–162th amino acid of MafG) were
prepared as follows. The sequences of the primers used for preparation
of MafGDZip were 5 0-AGCTGTCGACTATGAGAGGATCTCAC-
CA-3 0 (sequence in pQE vector) and 5 0-ATGAGCTCTGCTT-
CTGCTTCTCCAGCTCCT-30 (427–445th nucleotide of MafG). The
sequence of primers used for Zip were 5 0-TCGGGATCCTCAAG-
GCGGAGCTGCAGCAGG-3 0 (underline: BamHI site) and 5 0-
GTTCTGAGGTCATTACTGG-3 0 (sequence in pQE vector). PCR
was performed using KOD plus DNA polymerase (Toyobo, Tokyo,
Japan) and MafG cDNA in pQE82L as a template. The ampliﬁed
MafGDZip and Zip domain of MafG cDNAs were cut out with KpnI
and BamHI and with BamHI and HidIII, respectively, and subcloned
into pQE82L for expression in E. coli.
2.5. Preparation of HSP90a, HSP90b, and PDI constructs
Full-length cDNAs of HSP90a (GenBank accession no.
NM005348), HSP90b (GenBank accession no. NM007355), and pro-
tein disulﬁde isomerase (PDI, GenBank accession no. NM000918)
were obtained by RT-PCR using the speciﬁc primers. The sequences
of the primers used for HSP90a were 5 0-AAAGCGGCCGCT-
GGCGGTCACTTAGCCAAG-3 0 (underline: NotI; start codon is
downstream of this primer) and 5 0-AAAGGATCCTTGTAGAG-
TACTGAACAGGT-3 0 (underline: BamHI; stop codon is upstream
of this primer). The sequence of primers used for HSP90b were 5 0-
AAAGCGGCCGCCAAGATGCCTGAGGAAGTGC-3 0 (underline:
NotI; double underline: start codon) and 5 0-AAAGTC-
GACTTCCAACTATGAACTCCTAA-3 0 (underline: SalI; stop codon
is upstream of this primer). The sequence of primers used for PDI were
5 0-AAGAATTCGATCCGTGTCCGACATGCTG-3 0(underline: Eco-
RI; double under line: start codon) and 5 0-ACGGATCCTTGCG-
TATTACAGTTCATCT-3 0 (underline: BamHI; double underline:
stop codon). PCR was performed using a reaction mixture containing
10 pmol of each primer, 1.5 units of Gene Amp Hi Fidelity Taq DNA
polymerase (Applied Biosystems, Foster City, CA), and 100 ng of
cDNA synthesized from RNA of Hep3B cells, according to the follow-
ing protocol: 2 min at 94 C and 40 cycles of 30 s at 94 C, 30 s at
53 C, and 3 min at 70 C, plus a ﬁnal extension for 7 min at 70 C.
The ampliﬁed DNA was subcloned into pGEM by the T-A cloning
method according to the manufacturers instructions (Promega).
Full-length cDNAs of HSP90a, HSP90b, and PDI were then sub-
cloned into pQE vectors for expression in E. coli.
2.6. Surface plasmon resonance
As described above, His-tag fused proteins, PAS-A of Hif-1a,
MafG, MafGDZip, Zip of MafG, MafK, HSP90a, HSP90b, and
PDI were expressed in E. coli and puriﬁed by Ni-NTA agarose (Qia-
gen). Surface plasmon resonance experiments were performed with a
Biacore biosensor system 2000 (Biacore Inc., Uppsala, Sweden). The
PAS-A domain of HIF-1a was immobilized on the surface of CM5
sensor chips via N-hydroxysuccinimide (50 mM ﬁnal concentration)
and N-ethyl-N 0-(dimethylaminopropyl) carbodiimide (200 mM ﬁnal
concentration) according to the manufacturers instructions. The
remaining N-hydroxysuccinimide groups were inactivated with 1 M
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Fig. 1. Interaction between HIF-1a and MafG in vitro. Surface
plasmon resonance experiments were performed with a Biacore
biosensor system 2000. The domain of HIF-1a including bHLH and
PAS-A was immobilized on the surface of CM5 sensor chips with N-
hydroxysuccinimide and N-ethyl-N 0-(dimethylaminopropyl) carbodi-
imide. As a control of non-speciﬁc binding, the unreacted carboxy-
methyl groups of a sensor chip lacking immobilized HIF-1a domain
were blocked with ethanolamine. As analytes, MafG, MafGDZip, Zip
of MafG, MafK, HSP90a, HSP90b, and PDI were injected over the
ﬂow-cell at a ﬂow rate of 10 ll/min at 25 C. HBS buﬀer (0.01 M
Hepes, 0.15 M NaCl, 0.005% Tween 20, 3 mM EDTA [pH 7.4]) was
used as running buﬀer during the assay.
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acted carboxymethyl groups of a sensor chip lacking immobilized
PAS-A were blocked with ethanolamine. As an analyte, MafG,
MafGDZip, Zip of MafG, MafK, HSP90a, HSP90b, and PDI, was in-
jected over the ﬂow-cell in the ﬂow rate 10 ll/min at 25 C. HBS buﬀer
(0.01 M Hepes, 0.15 M NaCl, 0.005% Tween 20, 3 mM EDTA [pH
7.4]) was used as running buﬀer during the assay. Dissociation was ob-
served in running buﬀer without analyte. Data analyses were per-
formed using BIA evaluation ver.3.0 software.
2.7. Preparation of HIF-1a and Nrf2 constructs
To construct a mutant HIF-1a that would mimic the phosphory-
lated form of HIF-1a, Ser residues at 641 and 643 were changed to
Asp residues [17]. The following primers were used for PCR with
HIF-1a cDNA in the pCMV-Myc vector (Clontech)as a template: ﬁrst
set, sense primer 5 0-GATCCGGTACTAGAGGAACTGAAAAAC-30
(sequence in pCMV-Myc vector) and anti-sense primer 5 0-TGCA-
ATCAATATTTTAATGTCTTCCATACG-3 0; second set, sense pri-
mer 5 0-AAAATATTGATTGCAGATCCAGATCCTACC-30 (under-
line: changed nucleotides) and anti-sense primer 5 0-TCTAGTT-
GTGGTTTGTCCAA-3 0 (sequence in pCMV-Myc vector). Two
ampliﬁed fragments were puriﬁed, and PCR was performed again
using ﬁrst and last primers with the two fragments as the template
according to the method described previously [18]. The mutated
HIF-1a as subcloned into the pCMV-Myc vector. The full-length
cDNA of Nrf2 (GenBank accession no. NM006164) was ampliﬁed
by RT-PCR with speciﬁc primers: sense, 5 0- AAGGATCCATCATG
ATGGACTTGGAGCT-3 0 (underline: BamHI site; double underline:
start codon) and anti-sense primer, 5 0- AAGGTACCATT-
CAACATACTGACACTCC-3 0 (underline: KpnI site). The Nrf2
cDNA was subcloned into pcDNA3.1 (Invitrogen, Carlsbad, CA) with
the BamHI and KpnI sites for anti-sense cDNA for knockdown of
Nrf2 in mammalian cells.
2.8. Cell culture, transfection, and nuclear extraction
The human hepatic carcinoma cell line Hep3B was obtained from
the Cell Resource Center for Biomedical Research at the Institute of
Development, Aging, and Cancer of Tohoku University (Sendai, Ja-
pan). Hep3B cells were cultured in DMEM containing 10% FCS, pen-
icillin (100 units/mL) and streptomycin (100 lg/mL) and were
maintained at 37 C in 5% CO2 and 95% air (normoxia). For hypoxic
stimulation, the cells were cultured in a multi-gas incubator, APM-30D
(Astec, Shizuoka, Japan) whose conditions were set to 1% O2, 5% CO2
(hypoxia). Stable transfection for MafG knockdown with siRNA was
performed with pBAsi-hU6 Neo-MafG (6 lg) using calcium phos-
phate. Stable knockdown for MafG and Nrf2 with anti-sense cDNA
were performed using pcDNA vectors containing full-length anti-sense
cDNA of MafG or Nrf2. Empty vector of pBAsi or pcDNA was also
transfected as mock experiments. After incubation for 24 h, the culture
medium was replaced with fresh serum-reduced medium and incubated
for 6 or 12 h. Individual colonies were selected in the medium including
G418 (600 lg/ml). Expression of MafG or Nrf2 was analyzed by Wes-
tern blotting, and the RNA was analyzed by RT-PCR. The nuclear
extraction method used was that reported by Kang et al. [19].
2.9. Immunoﬂuorescence confocal microscopy
After transient transfection of pEGFP-N1-MafG, pEGFP-N1-
NoLS or pEGFP-N1-MafG-NoLS, Hep3B cells were grown on cover-
slips. After blocking with BSA, the coverslips were incubated with
anti-HIF-1a antibody (1:500 dilution) or anti-HSP90 antibody (1:500
dilution) and then incubated with Alexa Fluor 488 or 594 anti-mouse
secondary antibody (1:500 dilution, Invitrogen). The coverslips were
mounted for immunoﬂuorescence detection by confocal microscopy
(LSM-510, Carl Zeiss, Oberkochen, Germany). The nuclei were coun-
terstained using TO-PRO-3 (Invitrogen).
2.10. Detection of phosphorylated HIF-1a
The nuclear fractions of cells were harvested and subjected to SDS–
PAGE with gels containing phos-tag (Phos-tag Consortium, Hiro-
shima, Japan) and MnCl2 to detect phosphorylated HIF-1a. An acryl-
amide-dependent Phos-tag ligand (10 lM) and 2 eq of MnCl2 were
added to the separating gel before polymerization. After electrophore-
sis, the gel was soaked in a solution containing 25 mM Tris, 192 mM
glycine, 10% (v/v) methanol, and 5 mM EDTA for 10 min, and thenwas soaked in a solution containing 25 mM Tris, 192 mM glycine,
and 10% (v/v) methanol for another 10 min. The proteins on the gel
were electroblotted to nitrocellulose membrane.
2.11. Dual-luciferase reporter assay
Two copies of the HRE of EPO were subcloned into pGL3-SV40
(designated pGL3-SV40HRE) [15]. Both pGL3-SV40HRE and pRL-
TK were transfected into Hep3B cells using GenePORTERII (Gene
Therapy Systems, San Diego, CA) according to the manufacturers
instructions. The luciferase activity was measured 48 h later with a
luminometer (Lumat LB9507; Berthold Technologies, Bad Wildbad,
Germany) using the dual-luciferase reporter system (Promega).3. Results
3.1. Interaction between HIF-1a and MafG
The yeast two-hybrid system was used to screen a human
heart library, using the bHLH-PAS-A domain of HIF-1a as
bait. Forty-nine clones were positive for the X-a-gal assay un-
der Ade, His, Leu, and Trp selection. Among them, 20
clones were shown to encode the MafG coding region after
sequencing analysis and database searches. We tried to immu-
noprecipitate HIF-1a and MafG in Hep3B cells to conﬁrm the
interaction of these proteins, but did not obtain clear results
(data not shown). We therefore performed interaction analysis
with surface plasmon resonance in vitro (Fig. 1). The HIF-1a
bHLH-PAS-A domain and MafG, both of which possess the
His tag, were expressed in E. coli and puriﬁed in undenatured
condition. The bHLH-PAS-A domain was immobilized on
the sensor chip as a ligand and several proteins including
MafG, MafGDZip, Zip of MafG, MafK, HSP90a, HSP90b,
and PDI were used as analytes. MafG interacted with PAS-A
dose-dependently, although PDI as a negative control did not
interact with PAS-A. HSP90a/b is thought to interact with
PAS-A and PAS-B, and their interaction was weaker than that
of MafG. MafK is a homologue of MafG and also a bZip pro-
tein in small Maf family [20]. Interaction between PAS-A and
2360 K. Ueda et al. / FEBS Letters 582 (2008) 2357–2364MafK was weaker than that of MafG. MafG and MafK inter-
act their partner proteins such as Nrf2 in their bZip domains
[20]. We prepared a Zip-deﬁcient construct of MafG
(MafGDZip ) and Zip domain of MafG and analyzed by sur-
face Plasmon resonance. Very interestingly, PAS-A of HIF-
1a interacted with MafGDZip but not Zip. WhenMafG was re-
moved from the elution buﬀer, the binding was reduced
quickly, suggesting that the interaction between HIF-1a and
MafG was not strong. Recently, Lechertier et al. [16] found
the nucleolar localization sequence (NoLS) and succeeded inFig. 2. Interaction between HIF-1a and MafG in vivo using the NoLS metho
(D–F), NoLS-GFP (G–I), MafG-NoLS-GFP (J–O), and were incubated unde
E, H, and K) or anti-HSP90 antibody (N). Fluorescence of GFP was detectthe translocation of p45 (which forms a heterodimer with
MafG) in the nucleolus with the DsRed-MafG and NoLS fu-
sion proteins. We used this new technique. NoLS was inserted
into the GFP orMafG-GFP fusion protein and transfected into
Hep3B cells. The NoLS-GFP and MafG-NoLS-GFP fusion
proteins were successfully translocated into the nucleoli of
Hep3B cells (Fig. 2). When stained with HIF-1a antibody,
HIF-1a was detected in the nucleolus with MafG-NoLS-GFP
(Fig. 2J and K) but not NoLS-GFP (Fig. 2G and H). Staining
of cytoplasm in Fig. 2K seems to be stronger than that in Fig.d. Hep3B cells were transfected by a control vector (A–C), MafG-GFP
r hypoxia for 6 h. The cells were stained with anti-HIF-1a antibody (B,
ed (A, D, G, J, and M).
K. Ueda et al. / FEBS Letters 582 (2008) 2357–2364 23612H. As shown in Fig. 2D and E, over-expression of MafG re-
duced the accumulation of HIF-1a in nuclei. HSP90 which is
a partner of HIF-1a in cytoplasm remained in the cytoplasm.
These results suggest that HIF-1a interacts with MafG.A
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g a basal T4 promoter. The relative luciferase activity in mock under
ression with anti-sense and sense cDNAs. Full-length of MafG cDNA
ct was transfected in cells and selected with an antibiotic, G418, and
d. Empty vector was transfected into cells (mock). (D) PAS-A domain
nd luciferase reporter assay was performed using these cells. The full-
antibiotic, G-418, for stable knockdown. The relative luciferase activity
t-butylhydroquinone, tBHQ. Expression of HO-1 mRNA in mock and
(60 lM) was used as an inducer of HO-1. The values are indicated as
T-PCR. Nor, normoxia; Hyp, hypoxia; KD, knockdown; OE, over-
t-butylhydroquinone. Each experiment was done with three diﬀerent
iﬀerent from control, P < 0.01.
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typical hypoxia response factor, erythropoietin (EPO). The
MafG knockdown eﬃciently suppressed EPO induction in
Hep3B cells under hypoxia (Fig. 3A). Furthermore, HRE of
EPO was connected with the luciferase gene, and the reporter
assay was performed. The luciferase activity was also sup-
pressed by the MafG knockdown with siRNA (Fig. 3B). To
conﬁrm the speciﬁcity of MafG knockdown, we used an
anti-sense method with pcDNA including full-length of anti-
sense MafG cDNA. Knockdown of MafG by anti-sense
cDNA eﬃciently reduced the promoter activity (Fig. 3C). Sur-
prisingly transfection of pcDNA including sense MafG cDNA
(over-expression of MafG) also reduced the reporter activity.
This result is consistent with that of immunostaining (Fig.
2D and E). Over-expression of MafG inhibited accumulation
of HIF-1a in nuclei and inhibited hypoxic response. It may
be due to the formation of homodimer reported by Igarashi
et al. [20]. On the other hand, the bHLH-PAS-A domain of
HIF-1a was transfected into Hep3B (Fig. 3D). The luciferase
promoter activity was also suppressed. However, the knock-
down of the MafG partner, Nrf2, increased luciferase activity.
Heme oxygenase-1 (HO-1) is a typical Nrf2-dependent factor
[21]. Induction of HO-1 by an anti-oxidant (tert-butylhydro-
quinone, tBHQ) was investigated (Fig. 3E). Induction of
HO-1 was eﬃciently suppressed under hypoxia as well as by
knockdown of MafG. These results suggest that MafG playsC
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Fig. 4. Eﬀects of MafG knockdown on HIF-1a protein levels. (A) Hep3B ce
was investigated with whole cell lysates. SDS–polyacrylamide gel electroph
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expressed as means ± S.D. of three diﬀerent experiments on the graph. n.d.
polyacrylamide gel electrophoresis, including Phos-tag reagent (10 lM) and W
cells (80 lg of protein). KD, knockdown; Hyp, hypoxia; LMB, leptomycin
phosphorylated HIF-1a. (C) Phosphorylation-mimicking mutant of HIF-1a (
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knockdown cells, respectively. Values are expressed as means ± S.D. of three
**, signiﬁcantly diﬀerent from control, P < 0.01.an important role in hypoxic response of cells and the HIF-
1a function.
3.3. Mechanism of suppression of hypoxic response by MafG
knockdown
To investigate what happens in HIF-1a by the MafG knock-
down, HIF-1a protein levels and phosphorylation levels were
analyzed (Fig. 4).At least, the knockdowndid not change the to-
tal HIF-1a protein level (Fig. 4A). The nuclei of Hep3B cells
were extracted, and HIF-1a and phosphorylated HIF-1a were
detected by immunoblotting andphos-tag (Fig. 4B).HIF-1a lev-
els in the nuclei seemed to be decreased, although the phosphor-
ylation levelswere not changed.Next,we constructed anHIF-1a
mutant that would mimic phosphorylated HIF-1a by changing
two phosphorylation sites, the Ser residues at 641 and 643 toAsp
residues [17]. Transfection of wild-typeHIF-1a increased repor-
ter activity under hypoxia, andmutantHIF-1a further increased
the reporter activity. However, the suppression ratio of the lucif-
erase activity byMafGknockdownwasnot changed.We further
investigated HIF-1a translocation to nuclei by immunostaining
of Hep3B cells (Fig. 5). Under hypoxia, HIF-1a accumulated in
the nuclei ofHep3B cells, butHIF-1a remained in the cytoplasm
by theMafGknockdown.LeptomycinB, an inhibitor ofHIF-1a
for export from the nucleus to cytoplasm, successfully restored
the HIF-1a accumulation. These results suggest that MafG de-
tains HIF-1a in the nucleus.MafG KD
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Fig. 5. Localization of HIF-1a in MafG-knockdown cells. Cells were cultured for 6 h under hypoxia or hypoxia + LMB (20 nM). HIF-1a
localization was investigated by immunostaining with anti-HIF-1a antibody (A, D, and G), and nuclei were counterstained with TO-PRO-3 (B, E,
and H). Hypoxia control (mock) (A–C), MafG knockdown (D–F), and MafG knockdown and LMB (G–I). Stable knockdown of MafG was
prepared by siRNA with the pBAsi-hU6 Neo vector and mock which was transfected by an empty vector was used as control.
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Regulation of the nuclear translocation of inducible tran-
scription factors is an essential element of many signaling
pathways and can involve nuclear import, cytoplasmic reten-
tion, or nuclear export mechanisms. The stability of HIF-1a
is important in the regulation of the hypoxic response of cells.
The activation of the HIF-1 transcription factor by hypoxia is
a multi-step process. The regulation of HIF-1 appears to be
caused by posttranslational modiﬁcations, such as stabilization
of HIF-1a subunit, phosphorylation, and nuclear transloca-
tion, thus leading to proper transactivation activity. Hypoxia
inhibits hydroxylation of proline residues in HIF-1a and in-
duces accumulation of HIF-1a in the cytoplasm. HIF-1a activ-
ity is regulated through diﬀerent mechanisms involving
phosphorylation and interaction with cofactors [22,23]. In this
study, we used a yeast two-hybrid system to ﬁnd that MafG
interacted with the PAS-A (and/or bHLH) domain of HIF-
1a. We could not obtain clear results with immunoprecipita-
tion because the interaction between MafG and HIF-1a may
have been weak. However, we detected the interaction between
MafG and HIF-1a in vitro by using surface plasmon reso-
nance and in vivo by using the nucleolar localization signal.
Result of surface plasmon resonance indicated that PAS-A
of HIF-1a also interacted with MafK, a homologue of MafG
and a bZip protein. Deletion of Zip domain of MafG drasti-
cally reduced the interaction between PAS-A and MafG. Tothe best of our knowledge, this is the ﬁrst ﬁnding suggesting
the signiﬁcant contribution of protein–protein interactions
independent of the leucine zipper (Zip) structure to MafG
function. The MafG knockdown did not inﬂuence the HIF-
1a protein levels, suggesting that MafG is not a stabilizer pro-
tein such as Hsp90 and ARNT. MafG is a partner protein of
Nrf2, which is a key factor in oxidative stress in cells and which
induces anti-oxidant proteins such as HO-1 [20]. Hypoxia as
well as MafG knockdown eﬃciently inhibited HO-1 induction
in this study. The current study indicated that MafG aﬀected
cellular responses to both oxidative and hypoxic stress.
Accumulation of HIF-1a in the nucleus is regulated by phos-
phorylation as well as by the interaction with a nuclear pro-
tein, ARNT. Amino acid residues of Ser-641 and Ser-643 in
HIF-1a are targets of p44/p42 MAPK [17]. Inhibition of the
MAPK pathway impaired phosphorylation and nuclear accu-
mulation of HIF-1a, and treatment with leptomycin B, an
inhibitor of an HIF-1a export, restored the accumulation of
HIF-1a in the nucleus [17]. In this study, the MafG knock-
down inhibited HIF-1a accumulation in the nucleus, and treat-
ment with leptomycin B restored the accumulation. However,
the knockdown did not change HIF-1a phosphorylation. Fur-
thermore, Ser-641 and Ser-643 residues were changed to Asp
residues in the HIF-1a that mimics phosphorylated HIF-1a
[17]. The mutant could not recover the reduction of luciferase
reporter activity with HRE of EPO. Our ﬁndings suggest that
MafG did not inﬂuence HIF-1a kination by MAPK and that
2364 K. Ueda et al. / FEBS Letters 582 (2008) 2357–2364MafG accumulates HIF-1a by an unidentiﬁed mechanism.
Over-expression of MafG also suppressed accumulation of
HIF-1a in nuclei. Igarashi et al. [20] found that formation of
Maf homodimer regulate signaling negatively. In this case,
over-expression of MafG promoted homodimer formation
and luciferase reporter activity was inhibited by MafG over-
expression. The in vitro and cellular studies here collectively
provide a framework for understanding the physiological func-
tions of MafG in HIF regulation. We have described a novel
role for MafG in HIF-1a accumulation in the nucleus,
although further study is necessary to elucidate the underlying
mechanism.
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